Freezing gonadal tissue to protect fertility in people at risk
Studies tissue freezing for fertility in Turner syndrome or galactosemia.
Key facts
- Who runs it
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Where
- Bethesda, United StatesSee the site
- Trial code
- Registry title
- Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
- Status
- Recruiting
- People taking part
- 200 people, planned
- Started
- 13 Sept 2021
- Expected to end
- 31 Jul 2030
- Type of study
- Observational, 6 groups
- Record updated
- 30 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for young people at risk of losing fertility, who want ovarian or gonad tissue frozen for possible future use. This includes people with Turner Syndrome, galactosemia, early ovarian failure, low egg reserve, differences in sex development, or high-risk treatments that can harm fertility.
- Age
- 2 Years to 35 Years. Each group has its own age limit: Turner Syndrome 2 to 12 years, galactosemia 2-21, early ovarian failure up to 21 years, low egg reserve 2-24 years, high-risk treatment 2-35 years.
- Sex
- All sexes can join. The early ovarian failure group is for females only.
- Disease stage
- Turner Syndrome before the first period, or galactosemia, or early ovarian failure (POI) after the first period, with the last period within 2 years. Also low egg reserve, differences in sex development with planned removal of the gonads for medical reasons, or high risk of POI from treatment.
- Earlier treatment
- People in the treatment group must be receiving high-risk treatment that can harm the ovaries or testes, at the NIH Clinical Center. Females whose POI was caused by chemotherapy or radiation cannot join.
- Biomarker or test result
- For POI: 2 high FSH results taken over 1 month apart. Low egg reserve is shown by lab results or a poor response to egg-freezing stimulation. People with Turner Syndrome whose AMH cannot be detected cannot join.
Main reasons for not taking part
- Over 7 years old with a condition that prevents understanding and agreeing to the study
- A pelvic mass or tumor seen on ultrasound before surgery
- High risk of problems from anesthesia and surgery
- Pregnant or breastfeeding
- People with differences in sex development who choose to keep their gonads
The registry criteria, word for word
Show all 12 criteriaShow less
Who cannot take part
- Females with POI due to chemotherapy or radiation treatment
- Individuals with a pelvic mass tumor noted on pre-operative ultrasound, will undergo usual care for the underlying condition and will not undergo oophorectomy for ovarian tissue cryopreservation
- Individuals whose underlying medical condition significantly increases their risk of complications from anesthesia and surgery
- Individuals with Turner Syndrome who have an undetectable AMH based on testing laboratory reference range
- Individuals older than 7 years with psychological, psychiatric, or other conditions which prevent giving fully informed consent or assent
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Pregnancy or lactation
- Individuals with VSC who choose to retain gonads after clinical consulting
Other criteria
- INCLUSION CRITERIA:; In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Individuals with Turner Syndrome prior to menarche aged 2 years to 12 years whose families seek to store ovarian tissue for possible future use; Or; Individuals with galactosemia (age 2-21); Or; Adolescent females up to age 21 years old, who have undergone menarche and are subsequently diagnosed with premature ovarian insufficiency and their last menstrual period occurred within 2 years of presentation. Diagnosis of POI is based on 2 elevated FSH concentrations obtained over 1 month apart; Or; Children or adolescents aged 2-24 years old who have diminished ovarian reserve based on laboratory findings or who respond poorly to ovarian stimulation for egg freezing; Or; Individuals with variations in sex characteristics (or differences in sex development, DSD) including Turner syndrome with Y chromosome material who undergo prophylactic gonadectomy for clinical indications; Or; Individuals (2-35 years) receiving high-risk gonadotoxic therapy at the NIH Clinical Center who are at high risk for developing premature ovarian insufficiency and infertility
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Ability of subject, parents, or guardian to understand and the willingness to sign a written informed consent document
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 2 and 35 years old?
Where in United States
- National Institutes of Health Clinical CenterBethesda, United StatesContact: Veronica Gomez-Lobo, M.D.Taking people
About the trial
What the trial wants to find out
Background:
Read full original descriptionShow less
Turner Syndrome, galactosemia, and premature ovarian insufficiency are all conditions that may make it very hard or impossible for a person to become pregnant and have their own child. Researchers want to learn more about why this happens and if freezing Gonadal tissue allows for fertility preservation.
Objective:
To find out why people with certain conditions have can have premature ovarian insufficiency (POI or early menopause) and individuals with variations in sex characteristics have trouble getting pregnant and if freezing the gonads tissue from them will help to have their own child in the future.
Eligibility:
Individuals aged 2-21 who have Turner Syndrome or galactosemia. Also, females aged 13-21 with premature ovarian insufficiency, individuals with variations in sex characteristics, and individuals 2-35 receiving high-risk gonadotoxic therapy
Design:
Participants will be screened with a medical history.
Participants may have a physical exam and blood tests. Their body measurements may be taken. These include weight, height, arm span, skin fold, and sitting height. They may fill out surveys about their quality of life, body image, and health.
Participants may have a transabdominal pelvic ultrasound. A probe will be placed on their belly and will take pictures of the organs in the pelvis. They may have a transvaginal pelvic ultrasound performed while asleep in the operating room if needed.
Participants may have surgery to remove an gonads and skin biopsy. The removed tissue will be frozen and stored. The tissue will have to be stored for many years. NIH will pay to store the tissue for 1 year. After that, participants will have to pay for storage.
A piece of the gonads (no more than 20%) will be used for research
Travel, lodging and meals for participants traveling greater than 50 miles will be reimbursed based off the government rate. Local participants will not be reimbursed.
Participants will have a checkup 6 weeks after surgery one or more follow-up visits 6-18 months after surgery. They may have phone follow-up every 12-24 months after surgery.
Participation will last 30 years.
The 6 groups in the trial
- Adolescents with DOR
Adolescents with diminished ovarian reserve (DOR) who respond poorly to ovarian stimulation for egg freezing.
- Adolescents with POI
Adolescent females up to age 21 years old, who have undergone menarche and are subsequently diagnosed with POI and their last menstrual period occurred within 2 years of presentation.
- Individuals receiving high-risk gonadotoxic therapy
Individuals (2-35 years) receiving high-risk gonadotoxic therapy at the NIH Clinical Center who are at high risk for developing premature ovarian insufficiency and infertility.
- Individuals with variations in sex characteristics (or differences in sex development, DSD)
Individuals with variations in sex characteristics (or differences in sex development, DSD) who undergo gonadectomy for clinical indications.
- Turner Syndrome and galactosemia
Individuals with Turner Syndrome prior to menarche aged 2 years to 12 years, who have not previously demonstrated signs of premature ovarian insufficiency (FSH\>25 IU/L).
- Turner Syndrome with Y material
Children and adolescents who have Turner syndrome with Y material and undergo prophylactic gonadectomy.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Gonadal Tissue Freezing for Fertility Preservation in Individuals at Risk for Ovarian Dysfunction, Premature Ovarian Insufficiency and Clinically Indicated Gonadectomy
- Plain-language title
- Freezing gonadal tissue to protect fertility in people at riskGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Fit questions
- Built from NCT04948658, who can take part
- Record updated
- 30 October 2026